Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.
Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Wang JR, et al. Thyroid. 2019 Aug;29(8):1036-1043. doi: 10.1089/thy.2019.0133. Thyroid. 2019. PMID: 31319771 Free PMC article.
Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Jozaghi Y, et al. Head Neck. 2021 Jan;43(1):E7-E12. doi: 10.1002/hed.26527. Epub 2020 Nov 9. Head Neck. 2021. PMID: 33169506 Free PMC article.
Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma.
Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hofmann MC, Dadu R, Zafereo M, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BG, Skinner HD, Garden AS, Cabanillas ME. Iyer PC, et al. JCO Precis Oncol. 2018 Dec 20;2:PO.18.00173. doi: 10.1200/PO.18.00173. eCollection 2018 Dec. JCO Precis Oncol. 2018. PMID: 35135166 Free PMC article.
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.
Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Contrera KJ, et al. Among authors: gule monroe mk. Thyroid. 2023 Jan;33(1):129-132. doi: 10.1089/thy.2022.0506. Thyroid. 2023. PMID: 36503246 No abstract available.
Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ, Shakibai N, Su SY, Gule-Monroe MK, Roberts D, Brahimaj B, Williams MD, Ferrarotto R, Phan J, Gunn B, Raza S, DeMonte F, Hanna EY. Contrera KJ, et al. Among authors: gule monroe mk. Otolaryngol Head Neck Surg. 2023 Aug;169(2):435-440. doi: 10.1002/ohn.310. Epub 2023 Mar 1. Otolaryngol Head Neck Surg. 2023. PMID: 36856048
37 results